Bayer and Cradle Enter Multi-Year Strategic Alliance for Generative AI-Driven Protein Design
MONHEIM, Germany and AMSTERDAM, Netherlands — Bayer AG and generative AI biotechnology developer Cradle today announced a multi-year strategic collaboration to revolutionize molecular engineering within agricultural research. The partnership will embed Cradle’s advanced generative AI software platform directly into Bayer's crop science R&D pipeline, accelerating the discovery, design, and optimization of novel proteins and biological solutions.
Protein engineering is a critical component of modern agricultural science, driving the development of biological crop protection products, resilient crop genetics, and sustainable bio-based inputs. However, traditional protein design has historically relied on slow, iterative laboratory processes and trial-and-error methodologies that can take up to a decade to yield commercially viable solutions.
Accelerating Biological Input Discovery
The integration of Cradle’s generative AI software is designed to compress research timelines and improve the success rates of molecular engineering initiatives:
- Generative Molecular Design: Cradle's deep-learning models predict protein structural behavior and design optimal amino acid sequences virtually, allowing scientists to bypass the slow, expensive process of physically building and testing millions of non-viable mutations in the laboratory.
- Optimizing Thermal and Chemical Stability: The platform helps design proteins that remain functional under harsh environmental conditions—such as extreme heat, drought, or varying soil chemistry—ensuring biological inputs perform reliably in fields worldwide.
- Compressing R&D Cycles: By streamlining molecular design and predicting success rates virtually, the platform can compress discovery timelines, helping Bayer deliver next-generation biological crop protections and resilient seed traits to market much faster.
A Shift Toward Biological Innovations
Bayer’s multi-year collaboration with Cradle underscores the agricultural sector's growing focus on biological, sustainable input alternatives. By applying advanced generative AI to molecular biology, the partnership aims to accelerate the delivery of environmentally friendly, highly effective crop protection and genetic tools, supporting sustainable farming practices and securing global food production systems.
Source: https://www.bayer.com/en/us/news-stories/ai-enabled-antibody-discovery-and-optimization